Gynecologic Cancer News

Cancer research and advocacy funding disproportionately skewed toward certain subtypes, leaving many cancers with high mortality rates and those affecting Black patients underfunded, study results in JCO Oncology Practice showed.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

Women with ovarian cancer from underrepresented groups have a higher likelihood of in-hospital mortality vs. hospice mortality compared with their white counterparts, according to study results published in Obstetrics & Gynecology.

Cancer mortality in the U.S. is projected to decline again in 2024, but the number of new diagnoses should top 2 million for the first time, an annual report from the American Cancer Society revealed.

The FDA approved pembrolizumab in combination with chemoradiotherapy for the treatment of certain women with stage III to stage IVA cervical cancer.

Substance use disorders are more prevalent among survivors of certain types of cancer, according to study results published in JAMA Oncology.

The Advanced Research Projects Agency for Health, or ARPA-H, awarded $45 million to fast track the development of a “closed loop” implant for continuous monitoring of patients with cancer undergoing treatment with immunotherapy.

Vaccination against HPV and routine screening are the primary methods for cervical cancer prevention, and the convenience of at-home HPV tests may increase screening and lower cervical cancer prevalence in the U.S.

Asian, Black and Hispanic women with gynecologic cancers had a lower likelihood of being enrolled in clinical trials compared with white women, according to study findings published in JAMA Network Open.

An analysis of gynecologic cancer content on TikTok provided new insights into the advantages and disadvantages of patients using social media.